Frequently Asked Questions:
The COVID-19 pandemic has increased revenue in the bioanalytical testing services market. The virus’s widespread nature compelled nations to conduct large-scale bioanalytical testing services to gain insights into drug or vaccine development
North America dominated the global market for bioanalytical testing services in 2021.
Major pharmaceutical companies increasingly outsource their R&D operations to concentrate on their core competencies, one of the key factors fueling the market growth for bioanalytical testing services.
The biomarker testing segment had a major global market share in 2021.
The pharmaceutical & biopharmaceutical companies segment had a major global market share in 2021.